| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |